In vitro radiosensitization by pentoxifylline does not depend on p53 status

References

• Akudugu JM, Bell RS, Catton C, Davis AM, Griffin AM, O’Sullivan B, Waldron JN, Ferguson PC, Wunder JS, Hill RP. 2006. Wound healing morbidity in STS patients treated with preoperative radiotherapy in relation to in vitro skin fibroblast radiosensitivity, proliferative capacity and TGF-β activity. Radiotherapy and Oncology 78:17–26.
   PubMed Web of Science ®Google Scholar
• Akudugu JM, Theron T, Serafin AM, Böhm L. 2004. Influence of DNA double-strand break rejoining on clonogenic survival and micronucleus yield in human cell lines. International Journal of Radiation Biology 80:93–104.
   PubMed Web of Science ®Google Scholar
• Akudugu JM, Slabbert JP. 2008. Modulation of radiosensitivity in Chinese hamster lung fibroblasts by cisplatin. Canadian Journal of Physiology and Pharmacology 86:257–263.
   PubMed Web of Science ®Google Scholar
• Akudugu JM, Slabbert JP, Serafin A, Böhm L. 2000. Frequency of radiation-induced micronuclei in neuronal cells does not correlate with clonogenic survival. Radiation Research 153:62–67.
   PubMed Web of Science ®Google Scholar
• Anker L, Ohgaki H, Ludeke BI, Herrmann H-D, Kleihues P, Westphal M. 1993. p53 protein accumulation and gene mutations in human glioma cell lines. International Journal of Cancer 55:982–987.
   PubMed Web of Science ®Google Scholar
• Aylon Y, Ofir-Rosenfeld Y, Yabuta N, Lapi E, Nojima H, Lu X, Oren M. 2010. The Lats2 tumor suppressor augments p53-mediated apoptosis by promoting the nuclear proapoptotic function of ASPP1. Genes & Development 24:2420–2429.
   PubMed Web of Science ®Google Scholar
• Bache M, Pigorsch S, Dunst J, Würl P, Meye A, Bartel F, Schmidt H, Rath FW, Taubert H. 2001. Loss of G2/M arrest correlates with radiosensitization in two human sarcoma cell lines with mutant p53. International Journal of Cancer 96:110–117.
   PubMed Web of Science ®Google Scholar
• Binder AB, Serafin AM, Böhm LJF. 2000. Abrogation of G2/M-phase block enhances the cytotoxicity of daunorubicin, melphalan and cisplatin in TP53 mutant human tumour cells. Radiation Research 154:640–649.
   PubMed Web of Science ®Google Scholar
• Binder A, Theron T, Donninger H, Parker M, Böhm L. 2002. Radiosensitization and DNA repair inhibition by pentoxifylline in NIH3T3 p53 transfectants. International Journal of Radiation Biology 78: 991–1000.
   PubMed Web of Science ®Google Scholar
• Böhm L. 2006. Inhibition of homologous recombination repair with pentoxifylline targets G2 cells generated by radiotherapy and induces major enhancements of the toxicity of cisplatin and melphalan given after irradiation. Radiation Oncology 1:12.
   PubMed Web of Science ®Google Scholar
• Böhm L, Theron T, Binder A. 2000. Influence of pentoxifylline, A-802710, propentofylline and A-802715 (Hoechst) on the expression of cell cycle blocks and S-phase content after irradiation damage. Biochimica et Biophysica Acta 1499:1–10.
   PubMed Web of Science ®Google Scholar
• Böhm L, Roos WP, Serafin AM. 2003. Inhibition of DNA repair by pentoxifylline and related methylxanthine derivatives. Toxicology 193:153–160.
   PubMed Web of Science ®Google Scholar
• Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML, Wyllie AH. 1993. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362:849–852.
   PubMed Web of Science ®Google Scholar
• El-Deiry WS, Harper JW, O’Connor PM, Velculescu VE, Canman CE, Jackman J, Pietenpol JA, Burrell M, Hill DE, Wang Y, Wiman KG, Mercer WE, Kastan MB, Kohn KW, Elledge SJ, Kinzler KW, Vogelstein B. 1994. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Research 54:1169–1174.
   PubMed Web of Science ®Google Scholar
• Eley KW, Benedict SH, Chung TDK, Kavanagh BD, Broaddus WC, Schmidt-Ullrich RKA, Lin P-S. 2002. The effects of pentoxifylline on the survival of human glioma cells with continuous and intermittent stereotactic radiosurgery irradiation. International Journal of Radiation Oncology, Biology, and Physics 54:542–550.
   PubMed Web of Science ®Google Scholar
• Hermeking H, Fick D. 1994. Mediation of c-myc-induced apoptosis by p53. Science 265:2091–2093.
   PubMed Web of Science ®Google Scholar
• Hwang A, Muschel RJ. 1998. Radiation and the G2 phase of the cell cycle. Radiation Research 150:S52–S59.
   PubMed Web of Science ®Google Scholar
• Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Graig RW. 1991. Participation of p53 protein in the cellular response to DNA damage. Cancer Research 51:6304–6311.
   PubMed Web of Science ®Google Scholar
• Kawabe T. 2004. G2 checkpoint abrogators as anticancer drugs. Molecular Cancer Therapeutics 3:513–51.
   PubMed Web of Science ®Google Scholar
• Kim SH, Khil MS, Ryu S, Kim JH. 1993. Enhancement of radiation response on human carcinoma cell lines in culture by pentoxifylline. International Journal of Radiation Oncology, Biology, and Physics 25:61–65.
   PubMed Web of Science ®Google Scholar
• Kim EL, Yoshizato K, Kluwe L, Meissner H, Warnecke G, Zapf S, Westphal M, Deppert W, Giese A. 2005. Comparative assessment of the functional p53 status in glioma cells. Anticancer Research 25:213–224.
   PubMed Web of Science ®Google Scholar
• Kraus A, Gross MW, Knuechel R, Münkel K, Neff F, Schlegel J. 2000. Aberrant p21 regulation in radioresistant primary glioblastoma multiforme cells bearing wild-type p53. Journal of Neurosurgery 93:863–872.
   PubMed Web of Science ®Google Scholar
• Kuerbitz SJ, Plunkett BS, Walsh WV, Kastan MB. 1992. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proceedings of the National Academy of Sciences of the USA 89:7491–7495.
   PubMed Web of Science ®Google Scholar
• Li Y-X, Weber-Johnston K, Sun L-Q, Paschoud N, Mirimanoff R-O, Coucke PA. 1998. Effect of pentoxifylline in radiation-induced G2-phase delay and radiosensitivity of human colon and cervical cancer cells. Radiation Research 149:338–342.
   PubMed Web of Science ®Google Scholar
• Linke SP, Clarkin KC, Wahl GM. 1997. P53 mediates permanent arrest over multiple cell cycles in response to γ-irradiation.Cancer Research 57:1171–1179.
   PubMed Web of Science ®Google Scholar
• Lossaint G, Besnard E, Fisher D, Piette J, Dulić V. 2011. Chk1 is dispensable for G2 arrest in response to sustained DNA damage when the ATM/p53/p21 pathway is functional. Oncogene 30: 4261–4274.
   PubMed Web of Science ®Google Scholar
• Lowe SW, Schmitt EM, Smith SW, Osborne BA, Jacks T. 1993. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362:847–849.
   PubMed Web of Science ®Google Scholar
• Mellert HS, Stanek TJ, Sykes SM, Rauscher III FJ, Schultz DC, McMahon SB. 2011. Deacetylation of the DNA-binding domain regulates p53-mediated apoptosis. The Journal of Biological Chemistry 286:4264–4270.
   PubMed Web of Science ®Google Scholar
• Mokaleng BB, Akudugu JM. 2009. Modulation of the sensitivity in Chinese hamster cells to photons and fast neutrons by cisplatin, vinblastine and bleomycin. Canadian Journal of Physiology and Pharmacology 87: 347–352.
   PubMed Web of Science ®Google Scholar
• O’Connor PM. 1997. Mammalian G1 and G2 phase checkpoints. Cancer Surveys 29:151–82.
   PubMedGoogle Scholar
• O’Connor PM, Jackman J, Jondle D, Bhatia K, Magrath I, Kohn KW. 1993. Role of the p53 tumor suppressor gene in cell cycle arrest and radiosensitivity of Burkitt's lymphoma cell lines. Cancer Research 53:4776–4780.
   PubMed Web of Science ®Google Scholar
• O’Connor MJ, Martin NMB, Smith GCM. 2007. Targeted cancer therapies based on the inhibition of DNA strand break repair. Oncogene 26: 7816–7824.
   PubMed Web of Science ®Google Scholar
• Ono K, Masunaga S, Akaboshi M, Akuta K. 1994. Estimation of the initial slope of the cell survival curve after irradiation from micronucleus frequency in cytokinesis-blocked cells. Radiation Research 138:S101–S104.
   Web of Science ®Google Scholar
• Russell KJ, Wiens LW, Demers GW, Galloway DA, Le T, Rice GC, Bianco JA, Singer JW, Groudine M. 1996. Preferential radiosensitisation of G1 checkpoint-deficient cells by methylxanthines. International Journal of Radiation Oncology, Biology, and Physics 36: 1099–1106.
   PubMed Web of Science ®Google Scholar
• Sayan BS, Sayan AE, Knight RA, Melino G, Cohen GM. 2006. p53 is cleaved by caspases generating fragments localizing to mitochondria. The Journal of Biological Chemistry 281:13566–13573.
   PubMed Web of Science ®Google Scholar
• Stark GR, Taylor WR. 2006. Control of the G2/M transition. Molecular Biotechnology 32:227–248.
   PubMed Web of Science ®Google Scholar
• Smith RV, Waller ES, Doluisio JT, Bauza MT, Puri SK, Ho I, Lassman HB. 1986. Pharmacokinetics of orally administered pentoxifylline in humans. Journal of Pharmaceutical Sciences 75:47–52.
   PubMed Web of Science ®Google Scholar
• Strunz AM, Peschke P, Debus J, Waldeck W, Ehemann V, Kissel M. 2002. Preferential radiosensitization in p53-mutated human tumour cell lines by pentoxifylline-mediated disruption of the G2/M checkpoint control. International Journal of Radiation Biology 78:721–732.
   PubMed Web of Science ®Google Scholar
• Taylor WR, Stark GR. 2001. Regulation of the G2/M transition by p53. Oncogene 20:1803–1815.
   PubMed Web of Science ®Google Scholar
• Theron T, Böhm L. 1998. Cyclin B1 expression in response to abrogation of the radiation-induced G2/M block in HeLa cells. Cell Proliferation 31:49–57.
   PubMed Web of Science ®Google Scholar
• Theron T, Böhm L. 2000. Influence of the G2 cell cycle block abrogator pentoxifylline on the expression and subcellular location of cyclin B1 and p34cdc2 in HeLa cervical carcinoma cells. Cell Proliferation 33:39–50.
   PubMed Web of Science ®Google Scholar
• Theron T, Binder A, Verheye-Dua F, Böhm L. 2000. The role of G2-block abrogation, DNA double-strand break repair and apoptosis in the radiosensitisation of melanoma and squamous cell carcinoma cell lines by pentoxifylline. International Journal of Radiation Biology 76:1197–1208.
   PubMed Web of Science ®Google Scholar
• Vernimmen F, Verheye-Dua F, du Toit H, Böhm L. 1994. Effect of pentoxifylline on radiation damage and tumour growth. Strahlentherapie und Onkologie 10:595–601.
   Google Scholar
• Wagner AJ, Kokontis JM, Hay N. 1994. Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrests and the ability of p53 to induce p21waf1/cdk1. Genes & Development 8: 2817–2830.
   PubMed Web of Science ®Google Scholar
• Westphal M, Meissner H. 1998. Establishing human glioma-derived cell lines. In: Mather JP, Barnes D, editors. Methods in cell biology. Vol. 57. New York: Pergamon. pp. 147–165.
   Google Scholar